For the quarter ending 2026-03-31, CLRB has $11,119,761 in assets. $6,402,651 in debts. $8,347,090 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 8,347,090 | 13,196,033 | 12,554,289 | 11,041,027 |
| Prepaid expenses and other current assets | 920,038 | 842,432 | 1,067,409 | 1,576,579 |
| Total current assets | 9,267,128 | 14,038,465 | 13,621,698 | 12,617,606 |
| Property, plant & equipment, net | 339,697 | 549,405 | 595,271 | 647,549 |
| Operating lease right-of-use asset | 1,483,156 | 360,671 | 380,841 | 400,248 |
| Other long-term assets | 29,780 | 29,780 | 29,780 | 29,780 |
| Total assets | 11,119,761 | 14,978,321 | 14,627,590 | 13,695,183 |
| Lease liability, current | - | 100,189 | 96,034 | 92,022 |
| Accounts payable and accrued liabilities | 4,724,826 | 4,423,548 | 4,014,682 | 4,678,713 |
| Warrant liability | 149,000 | 226,000 | 801,650 | 1,095,926 |
| Total current liabilities | 4,873,826 | 4,749,737 | 4,912,366 | 5,866,661 |
| Lease liability, net of current portion | 1,528,825 | 309,397 | 335,895 | 361,487 |
| Total liabilities | 6,402,651 | 5,059,134 | 5,248,261 | 6,228,148 |
| Series d preferred stock, 111.11 shares authorized, issued and outstanding as of march 31, 2026 and december 31, 2025 | 1,382,023 | 1,382,023 | 1,382,023 | 1,382,023 |
| Series e-2 preferred stock, 1,225.00 shares authorized 35.60 and 35.60 shares issued and outstanding as of december 31, 2025 and 2024, respectively-Series E2Preferred Stock | - | 520,778 | - | - |
| Series e-2 preferred stock, 1,225.00 shares authorized 35.60 shares issued and outstanding as of march 31, 2026 and december 31, 2025 | 520,778 | - | 520,778 | 520,778 |
| Common stock, 0.00001 par value 170,000,000 shares authorized 4,240,129 shares issued and outstanding as of march 31, 2026 and december 31, 2025 | 42 | 42 | 32 | 18 |
| Additional paid-in capital | 277,601,713 | 277,149,844 | 271,314,776 | 264,958,619 |
| Accumulated deficit | -274,787,446 | -269,133,500 | -263,838,280 | -259,394,403 |
| Total stockholders' equity (deficit) | 3,335,087 | 8,537,164 | 7,997,306 | 6,085,012 |
| Total liabilities and stockholders' equity | 11,119,761 | 14,978,321 | 14,627,590 | 13,695,183 |
Cellectar Biosciences, Inc. (CLRB)
Cellectar Biosciences, Inc. (CLRB)